Performance
5 Days
-0.76%
1 Month
2.04%
3 Months
3.62%
6 Months
2.46%
1 Year
9.53%
2 Year
13.00%
Key data
Stock price
$24.80
DAY RANGE
$24.61 - $25.11
52 WEEK RANGE
$20.43 - $25.19
52 WEEK CHANGE
$0.09
DIVIDEND
$0.3438
EX-DIVIDEND DATE
08/01/2024
NEXT EARNINGS DATE
N/A
Company detail
CEO: J. Andrew Don
Region: US
Website: www.nephrogenex.com
Employees: 1,700
IPO year: -
Issue type:
Market: NYSE
Industry:
Sector:
Region: US
Website: www.nephrogenex.com
Employees: 1,700
IPO year: -
Issue type:
Market: NYSE
Industry:
Sector:
NephroGenex, Inc. is a pharmaceutical company, which focuses on the development of therapeutics to treat kidney disease, an area of significant unmet medical need. It is developing Pyridorin, a small molecule drug that is acting inhibitor of the pathogenic oxidative chemistries which are elevated in diabetic patients. The company was founded by Billy G. Hudson, J. Wesley Fox Ahmann and Tryggvason Karl on May 25, 2004 and is headquartered in Raleigh, NC.
Recent news